UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(RULE 13D-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13D-1(B), (C) AND (D) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13D-2(B)
(AMENDMENT NO. 2)*
Intrabiotics Pharmaceuticals, Inc.
(Name of Issuer)
Common Stock, $0.001 par value
(Title of Class of Securities)
46116T506
(CUSIP Number)
December 31, 2003
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[X] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the Notes).
----------------------- ------------------
CUSIP NO. 46116T506 13G PAGE 2 OF 4 PAGES
----------------------- ------------------
--------------------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Chilton Investment Company, Inc.
13-3667517
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) [ ]
(b) [X]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
State of Delaware
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
0
NUMBER OF ------------------------------------------------------------------
SHARES 6. SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
EACH ------------------------------------------------------------------
REPORTING 7. SOLE DISPOSITIVE POWER
PERSON
WITH 0
------------------------------------------------------------------
8. SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
--------------------------------------------------------------------------------
10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See
Instructions)
[ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON (See Instructions)
IA
--------------------------------------------------------------------------------
----------------------- ------------------
CUSIP NO. 46116T506 13G PAGE 2 OF 4 PAGES
----------------------- ------------------
Pursuant to Rule 13d-2(b) of Regulation 13D-G under the Securities Exchange
Act of 1934, as amended, the Schedule 13G initially filed on April 1, 2002 by
Chilton Investment Company, Inc. (the "Reporting Person") with respect to the
Common Stock, $0.001 par value (the "Common Stock"),of Intrabiotics
Pharmaceuticals, Inc., a Delaware corporation, as amended by Amendment No. 1
to the Scheduled 13G filed on February 14, 2003 (the "Schedule 13G"),is
hereby amended by this Amendment No. 2 to the Schedule 13G to report a change
in the information reported in the Schedule 13G. Since the Reporting Person
no longer beneficially owns any of the Common Stock, this filing constitutes
the Reporting Person's final statement on Schedule 13G with respect to the
Common Stock. The Schedule 13G is hereby amended as follows:
Items 3, 4, 5 and 10 are hereby amended and restated in their entirety to
read:
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 13D-2(B) OR
(C), CHECK WHETHER THE PERSON FILING IS A:
(a) [ ] Broker or dealer registered under Section 15 of the Exchange Act.
(b) [ ] Bank as defined in Section 3(a)(6) of the Exchange Act.
(c) [ ] Insurance company as defined in Section 3(a)(19) of the Exchange
Act.
(d) [ ] Investment company registered under Section 8 of the Investment
Company Act.
(e) [X] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
(f) [ ] An employee benefit plan or endowment fund in accordance with Rule
13d-1(b)(1)(ii)(F);
(g) [ ] A parent holding company or control person in accordance with Rule
13d-1(b)(1)(ii)(G);
(h) [ ] A savings association as defined in Section 3(b) of the Federal
Deposit Insurance Act;
(i) [ ] A church plan that is excluded from the definition of an investment
company under Section 3(c)(14) of the Investment Company Act;
(j) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
----------------------- ------------------
CUSIP NO. 46116T506 13G PAGE 3 OF 4 PAGES
----------------------- ------------------
ITEM 4. OWNERSHIP.
(a) Amount beneficially owned: 0 shares
(b) Percent of class: 0%
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct
the vote: 0
(ii) Shared power to vote or to direct
the vote: 0
(iii) Sole power to dispose or to direct
the disposition of: 0
(iv) Shared power to dispose or to direct
the disposition of: 0
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
If this statement is being filed to report the fact that as
of the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of
securities, check the following [X].
ITEM 10. CERTIFICATIONS.
By signing below I certify that, to the best of my knowledge and belief, the
securities referred to above were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the issuer of
the securities and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.
Date: February 13, 2004
Chilton Investment Company, Inc.
By: /s/
---------------------------------------
Name: James Steinthal
Title: Senior Vice President